INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,305,382 | -7.1% | 34,168 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,405,153 | -98.6% | 34,176 | -98.0% | 0.00% | -98.5% |
| Q1 2023 | $97,830,284 | -33.9% | 1,704,087 | -35.4% | 0.06% | -38.7% |
| Q4 2022 | $147,915,655 | +10.0% | 2,638,059 | -58.4% | 0.11% | +5.0% |
| Q3 2022 | $134,523,389 | -24.1% | 6,345,076 | +93.4% | 0.10% | -17.2% |
| Q2 2022 | $177,227,000 | -16.0% | 3,280,148 | -0.1% | 0.12% | +19.6% |
| Q1 2022 | $210,960,000 | -16.0% | 3,282,892 | -12.4% | 0.10% | -2.9% |
| Q4 2021 | $251,097,000 | -11.5% | 3,748,284 | -9.5% | 0.10% | -15.3% |
| Q3 2021 | $283,762,000 | -10.4% | 4,143,725 | -10.8% | 0.12% | -8.8% |
| Q2 2021 | $316,843,000 | -1.5% | 4,643,069 | -0.3% | 0.14% | -7.5% |
| Q1 2021 | $321,763,000 | +7.2% | 4,657,163 | +0.8% | 0.15% | +5.8% |
| Q4 2020 | $300,071,000 | +56.9% | 4,622,163 | +14.1% | 0.14% | +39.0% |
| Q3 2020 | $191,235,000 | -3.0% | 4,049,872 | -3.5% | 0.10% | -9.9% |
| Q2 2020 | $197,132,000 | +2.5% | 4,195,186 | -2.6% | 0.11% | -15.9% |
| Q1 2020 | $192,346,000 | -23.5% | 4,305,926 | -0.2% | 0.13% | +2.3% |
| Q4 2019 | $251,353,000 | +29.7% | 4,312,847 | +33.7% | 0.13% | +22.9% |
| Q3 2019 | $193,814,000 | +6.8% | 3,226,462 | -0.7% | 0.10% | +7.1% |
| Q2 2019 | $181,449,000 | +13.3% | 3,248,870 | +13.1% | 0.10% | +10.1% |
| Q1 2019 | $160,102,000 | +62.5% | 2,873,324 | +31.5% | 0.09% | +41.3% |
| Q4 2018 | $98,524,000 | -25.6% | 2,184,563 | +8.7% | 0.06% | -11.3% |
| Q3 2018 | $132,341,000 | +4.5% | 2,009,131 | +2.2% | 0.07% | -1.4% |
| Q2 2018 | $126,652,000 | +42.9% | 1,966,341 | +22.8% | 0.07% | +38.5% |
| Q1 2018 | $88,604,000 | +15.4% | 1,601,087 | -0.2% | 0.05% | +10.6% |
| Q4 2017 | $76,756,000 | -25.3% | 1,603,752 | -21.2% | 0.05% | -28.8% |
| Q3 2017 | $102,741,000 | -8.3% | 2,035,288 | -1.0% | 0.07% | -13.2% |
| Q2 2017 | $112,068,000 | – | 2,055,913 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |